Literature DB >> 23997374

A regularized Hotelling's T2 test for pathway analysis in proteomic studies.

Lin S Chen1, Debashis Paul, Ross L Prentice, Pei Wang.   

Abstract

Recent proteomic studies have identified proteins related to specific phenotypes. In addition to marginal association analysis for individual proteins, analyzing pathways (functionally related sets of proteins) may yield additional valuable insights. Identifying pathways that differ between phenotypes can be conceptualized as a multivariate hypothesis testing problem: whether the mean vector μ of a p-dimensional random vector X is μ0 . Proteins within the same biological pathway may correlate with one another in a complicated way, and type I error rates can be inflated if such correlations are incorrectly assumed to be absent. The inflation tends to be more pronounced when the sample size is very small or there is a large amount of missingness in the data, as is frequently the case in proteomic discovery studies. To tackle these challenges, we propose a regularized Hotelling's T2 (RHT) statistic together with a non-parametric testing procedure, which effectively controls the type I error rate and maintains good power in the presence of complex correlation structures and missing data patterns. We investigate asymptotic properties of the RHT statistic under pertinent assumptions and compare the test performance with four existing methods through simulation examples. We apply the RHT test to a hormone therapy proteomics data set, and identify several interesting biological pathways for which blood serum concentrations changed following hormone therapy initiation.

Entities:  

Keywords:  Hotelling’s T2; pathway analysis; proteomics; regularization

Year:  2011        PMID: 23997374      PMCID: PMC3755504          DOI: 10.1198/jasa.2011.ap10599

Source DB:  PubMed          Journal:  J Am Stat Assoc        ISSN: 0162-1459            Impact factor:   5.033


  26 in total

1.  A shrinkage approach to large-scale covariance matrix estimation and implications for functional genomics.

Authors:  Juliane Schäfer; Korbinian Strimmer
Journal:  Stat Appl Genet Mol Biol       Date:  2005-11-14

2.  Pathway-based approaches for analysis of genomewide association studies.

Authors:  Kai Wang; Mingyao Li; Maja Bucan
Journal:  Am J Hum Genet       Date:  2007-12       Impact factor: 11.025

3.  Analysis of gene sets based on the underlying regulatory network.

Authors:  Ali Shojaie; George Michailidis
Journal:  J Comput Biol       Date:  2009-03       Impact factor: 1.479

4.  Sparse linear discriminant analysis for simultaneous testing for the significance of a gene set/pathway and gene selection.

Authors:  Michael C Wu; Lingsong Zhang; Zhaoxi Wang; David C Christiani; Xihong Lin
Journal:  Bioinformatics       Date:  2009-01-25       Impact factor: 6.937

5.  Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays.

Authors:  U Alon; N Barkai; D A Notterman; K Gish; S Ybarra; D Mack; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

Review 7.  The women's health initiative: lessons learned.

Authors:  Ross L Prentice; Garnet L Anderson
Journal:  Annu Rev Public Health       Date:  2008       Impact factor: 21.981

8.  PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.

Authors:  Vamsi K Mootha; Cecilia M Lindgren; Karl-Fredrik Eriksson; Aravind Subramanian; Smita Sihag; Joseph Lehar; Pere Puigserver; Emma Carlsson; Martin Ridderstråle; Esa Laurila; Nicholas Houstis; Mark J Daly; Nick Patterson; Jill P Mesirov; Todd R Golub; Pablo Tamayo; Bruce Spiegelman; Eric S Lander; Joel N Hirschhorn; David Altshuler; Leif C Groop
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

9.  Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.

Authors:  Jacques E Rossouw; Mary Cushman; Philip Greenland; Donald M Lloyd-Jones; Paul Bray; Charles Kooperberg; Mary Pettinger; Jennifer Robinson; Susan Hendrix; Judith Hsia
Journal:  Arch Intern Med       Date:  2008-11-10

10.  Can biomarkers identify women at increased stroke risk? The Women's Health Initiative Hormone Trials.

Authors:  Charles Kooperberg; Mary Cushman; Judith Hsia; Jennifer G Robinson; Aaron K Aragaki; John K Lynch; Alison E Baird; Karen C Johnson; Lewis H Kuller; Shirley A A Beresford; Beatriz Rodriguez
Journal:  PLoS Clin Trials       Date:  2007-06-15
View more
  9 in total

1.  Power calculation for overall hypothesis testing with high-dimensional commensurate outcomes.

Authors:  Yueh-Yun Chi; Matthew J Gribbin; Jacqueline L Johnson; Keith E Muller
Journal:  Stat Med       Date:  2013-09-30       Impact factor: 2.373

2.  T2-DAG: a powerful test for differentially expressed gene pathways via graph-informed structural equation modeling.

Authors:  Jin Jin; Yue Wang
Journal:  Bioinformatics       Date:  2021-11-10       Impact factor: 6.937

3.  A selective overview of feature screening for ultrahigh-dimensional data.

Authors:  Liu JingYuan; Zhong Wei; L I RunZe
Journal:  Sci China Math       Date:  2015-08-22       Impact factor: 1.331

4.  A penalized EM algorithm incorporating missing data mechanism for Gaussian parameter estimation.

Authors:  Lin S Chen; Ross L Prentice; Pei Wang
Journal:  Biometrics       Date:  2014-01-28       Impact factor: 2.571

5.  Feature Screening via Distance Correlation Learning.

Authors:  Runze Li; Wei Zhong; Liping Zhu
Journal:  J Am Stat Assoc       Date:  2012-07-01       Impact factor: 5.033

6.  Statistical inference of genetic pathway analysis in high dimensions.

Authors:  Yang Liu; Wei Sun; Alexander P Reiner; Charles Kooperberg; Qianchuan He
Journal:  Biometrika       Date:  2019-07-13       Impact factor: 2.445

7.  Exploratory plasma proteomic analysis in a randomized crossover trial of aspirin among healthy men and women.

Authors:  Xiaoliang Wang; Ali Shojaie; Yuzheng Zhang; David Shelley; Paul D Lampe; Lisa Levy; Ulrike Peters; John D Potter; Emily White; Johanna W Lampe
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

8.  Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer.

Authors:  Dongqing Huang; Shrabanti Chowdhury; Hong Wang; Sara R Savage; Richard G Ivey; Jacob J Kennedy; Jeffrey R Whiteaker; Chenwei Lin; Xiaonan Hou; Ann L Oberg; Melissa C Larson; Najmeh Eskandari; Davide A Delisi; Saverio Gentile; Catherine J Huntoon; Uliana J Voytovich; Zahra J Shire; Qing Yu; Steven P Gygi; Andrew N Hoofnagle; Zachary T Herbert; Travis D Lorentzen; Anna Calinawan; Larry M Karnitz; S John Weroha; Scott H Kaufmann; Bing Zhang; Pei Wang; Michael J Birrer; Amanda G Paulovich
Journal:  Cell Rep Med       Date:  2021-12-21

9.  Lipidome profile predictive of disease evolution and activity in rheumatoid arthritis.

Authors:  Jung Hee Koh; Sang Jun Yoon; Mina Kim; Seonghun Cho; Johan Lim; Youngjae Park; Hyun-Sook Kim; Sung Won Kwon; Wan-Uk Kim
Journal:  Exp Mol Med       Date:  2022-02-15       Impact factor: 12.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.